Professor Jung Won-gyu's team at Gangdong Kyunghee University Hospital won the Best Foster Award at the Asian Dementia Association International Conference
May 23, 2025
A research team led by Professor Jung Won-kyu of Radiation Oncology at Gangdong Kyunghee University Hospital (Director Lee Woo-in) won the Best Foster Award at the 19th Asian Dementia Association International Conference (ASAD) and the Korean Dementia Association International Conference (IC-KDA 2025) held at Lotte Hotel World in Seoul for three days from May 8.
Professor Jung Won-gyu's team presented the research results under the theme of 「Effectiveness and Safety Assessment using low-dose radiation therapy in Alzheimer's disease: Evaluation of Efficiency and Safety Using Low Dose Radiation Therapy with Alzheimer's Disease: A Protocol for Multicenter Phase II Clinical Trial」. This study is a multicenter phase 2 clinical trial that applied low-dose radiation therapy to patients with early Alzheimer's disease, confirming significant therapeutic effects such as improved cognitive function and reduced amyloid plaque.
In particular, the effect was remarkable in the ultra-low-dose group, and cognitive evaluation indicators such as ADAS-K, K-MMSE-2, and CDR-SB and improvements were also shown in imaging and hematologic tests. Biometric indicators such as a decrease in inflammatory markers (TNF-α, IL-1β) and an increase in Aβ42/40 levels were also confirmed, and it is evaluated as a non-pharmaceutical treatment that has been proven to be safe as there has been no response for more than a year after treatment.
Professor Jung Won-gyu "Taken together, low-dose radiation is a very effective non-pharmaceutical treatment method for improving early Alzheimer's disease and has a very good profile in terms of safety."We will continue to focus on research and contribute to the treatment of dementia.", he expressed his feelings.
Meanwhile, Professor Chung's research team has been conducting research using low-dose radiation for many years to overcome the limitations of dementia drugs and suggest new treatment methods. Through cell and individual experiments, scientific evidence related to the improvement of Alzheimer's disease such as anti-inflammatory, neuroprotection, and Aβ/tau reduction after low-dose radiation was identified, and the results were published in international journals.
Professor Jung Won-gyu's team presented the research results under the theme of 「Effectiveness and Safety Assessment using low-dose radiation therapy in Alzheimer's disease: Evaluation of Efficiency and Safety Using Low Dose Radiation Therapy with Alzheimer's Disease: A Protocol for Multicenter Phase II Clinical Trial」. This study is a multicenter phase 2 clinical trial that applied low-dose radiation therapy to patients with early Alzheimer's disease, confirming significant therapeutic effects such as improved cognitive function and reduced amyloid plaque.
In particular, the effect was remarkable in the ultra-low-dose group, and cognitive evaluation indicators such as ADAS-K, K-MMSE-2, and CDR-SB and improvements were also shown in imaging and hematologic tests. Biometric indicators such as a decrease in inflammatory markers (TNF-α, IL-1β) and an increase in Aβ42/40 levels were also confirmed, and it is evaluated as a non-pharmaceutical treatment that has been proven to be safe as there has been no response for more than a year after treatment.
Professor Jung Won-gyu "Taken together, low-dose radiation is a very effective non-pharmaceutical treatment method for improving early Alzheimer's disease and has a very good profile in terms of safety."We will continue to focus on research and contribute to the treatment of dementia.", he expressed his feelings.
Meanwhile, Professor Chung's research team has been conducting research using low-dose radiation for many years to overcome the limitations of dementia drugs and suggest new treatment methods. Through cell and individual experiments, scientific evidence related to the improvement of Alzheimer's disease such as anti-inflammatory, neuroprotection, and Aβ/tau reduction after low-dose radiation was identified, and the results were published in international journals.
|
This article was translated by Naver AI translator.
